Stigma in gestational diabetes 30 March 2026 Our research impact Challenge Diabetes stigma can harm emotional and social wellbeing, self-care, and access to healthcare. While stigma in other types of diabetes has been studied, little was known about stigma in gestational diabetes (GDM). There has also been no tool to measure GDM-related stigma, limiting efforts to address it. Bold idea With support from Diabetes Australia, this study explored how Australian women with GDM experience stigma and co-developed the first comprehensive questionnaire to measure it. This project was led by Dr Elizabeth Holmes-Truscott who has lived experience of GDM and is Deputy Director of the Australian Centre for Behavioural Research in Diabetes (a partnership between Diabetes Victoria and Deakin University). Impact The study gave new insights into women’s experiences of GDM-related stigma. Women described stigma driven by stereotypes and blame, shaped by social expectations about pregnancy and motherhood, media messages, and inconsistent healthcare. They reported emotional and social impacts of stigma, challenges with self-care, and reduced autonomy in healthcare decisions. Women also identified protective factors. These included supportive healthcare and social networks, self-belief, and greater community awareness of GDM. Findings informed the co-design of questions to measure GDM-related stigma, now ready for further testing. This tool will support future research to measure prevalence, understand impacts, and evaluate stigma-reduction efforts. This work also supports Elizabeth’s co-leadership of the Global Pledge to End Diabetes Stigma. Learn more about diabetes research and our research impact.
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
Blog 31 March 2026 Searching to improve diabetes treatment and prevention strategies Professor John Wentworth received funding from the Diabetes Australia Research Program in 2022 to develop a finger prick blood test to diagnose type 1 diabetes early, well before symptoms appear. Continue Reading